ExploreWatchlistsPricing
  1. JP-listed companies
  2. TEIJIN LIMITED
  3. Financials
  4. Inventories

TEIJIN LIMITED (3401)

Market cap
¥318.2B
P/E ratio
6.9x
Teijin develops and manufactures high-performance materials, fibers, and healthcare products including aramid fibers, pharmaceuticals, and medical devices.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndInventories (Million JPY)YoY (%)
Mar 31, 2026208,820-8.02%
Mar 31, 2025227,032+50.34%
Mar 31, 2024151,017+19.97%
Mar 31, 2023125,878+21.74%
Mar 31, 2022103,399+15.28%
Mar 31, 202189,693-7.47%
Mar 31, 202096,935-1.82%
Mar 31, 201998,727+8.19%
Mar 31, 201891,257+8.29%
Mar 31, 201784,272-1.97%
Mar 31, 201685,965+9.71%
Mar 31, 201578,357

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat